مکتبة رقمیه للعلوم الطبيه
Your cart is empty.
  • Cart
  • Lists
    Your lists Log in to create your own lists
  • Log in to your account
  • Your cookies
  • Search history
  • Advanced search
  • Authority search
  • Tag cloud
  • Library

Log in to your account

  1. Home
  2. Details for: Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands.
Normal view MARC view ISBD view

Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands. [electronic resource]

By:
  • Laros-van Gorkom, B A P
Contributor(s):
  • Huisman, C A M
  • Wijermans, P W
  • Schipperus, M R
Producer: 20080108Description: 333-8 p. digitalISSN:
  • 0300-2977
Subject(s):
  • Alemtuzumab
  • Antibodies, Monoclonal -- administration & dosage
  • Antibodies, Monoclonal, Humanized
  • Antibodies, Neoplasm -- administration & dosage
  • Antigens, CD -- drug effects
  • Antigens, Neoplasm -- drug effects
  • Aspergillosis -- chemically induced
  • CD52 Antigen
  • Drug Evaluation
  • Drug Resistance, Neoplasm
  • Glycoproteins -- drug effects
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell -- drug therapy
  • Medical Records
  • Netherlands
  • Opportunistic Infections -- chemically induced
  • Pneumonia, Pneumocystis -- chemically induced
  • Remission Induction
  • Retrospective Studies
  • Surveys and Questionnaires
  • Treatment Outcome
  • Vidarabine -- analogs & derivatives
In: The Netherlands journal of medicine vol. 65
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Cancel rating. Average rating: 0.0 (0 votes)
  • Holdings ( 0 )
  • Title notes ( 1 )
  • Comments ( 0 )
No physical items for this record

Publication Type: Evaluation Study; Journal Article

There are no comments on this title.

Log in to your account to post a comment.

Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands.

APA

Laros-van Gorkom B. A. P., Huisman C. A. M., Wijermans P. W. & Schipperus M. R. (20080108). Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands. : The Netherlands journal of medicine.

Chicago

Laros-van Gorkom B A P, Huisman C A M, Wijermans P W and Schipperus M R. 20080108. Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands. : The Netherlands journal of medicine.

Harvard

Laros-van Gorkom B. A. P., Huisman C. A. M., Wijermans P. W. and Schipperus M. R. (20080108). Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands. : The Netherlands journal of medicine.

MLA

Laros-van Gorkom B A P, Huisman C A M, Wijermans P W and Schipperus M R. Experience with alemtuzumab in treatment of chronic lymphocytic leukaemia in the Netherlands. : The Netherlands journal of medicine. 20080108.

  • Print
  • Cite
  • Add to your cart (remove)
  • Save record
    BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
  • More searches
    Search for this title in:
    Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Visit web site